These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 20023949)
1. Densely packed Gd(III)-chelates with fast water exchange on a calix[4]arene scaffold: a potential MRI contrast agent. Schühle DT; Polásek M; Lukes I; Chauvin T; Tóth E; Schatz J; Hanefeld U; Stuart MC; Peters JA Dalton Trans; 2010 Jan; (1):185-91. PubMed ID: 20023949 [TBL] [Abstract][Full Text] [Related]
2. Calix[4]arenes as molecular platforms for magnetic resonance imaging (MRI) contrast agents. Schühle DT; Schatz J; Laurent S; Vander Elst L; Muller RN; Stuart MC; Peters JA Chemistry; 2009; 15(13):3290-6. PubMed ID: 19206118 [TBL] [Abstract][Full Text] [Related]
3. Liposomes with conjugates of a calix[4]arene and a Gd-DOTA derivative on the outside surface; an efficient potential contrast agent for MRI. Schühle DT; van Rijn P; Laurent S; Vander Elst L; Muller RN; Stuart MC; Schatz J; Peters JA Chem Commun (Camb); 2010 Jun; 46(24):4399-401. PubMed ID: 20467663 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and relaxivity studies of a tetranuclear gadolinium(III) complex of DO3A as a contrast-enhancing agent for MRI. Jebasingh B; Alexander V Inorg Chem; 2005 Dec; 44(25):9434-43. PubMed ID: 16323930 [TBL] [Abstract][Full Text] [Related]
5. Preparation and in vitro evaluation of GdDOTA-(BOM)4; a novel angiographic MRI contrast agent. Hovland R; Aasen AJ; Klaveness J Org Biomol Chem; 2003 May; 1(10):1707-10. PubMed ID: 12926358 [TBL] [Abstract][Full Text] [Related]
6. A benzene-core trinuclear GdIII complex: towards the optimization of relaxivity for MRI contrast agent applications at high magnetic field. Livramento JB; Helm L; Sour A; O'Neil C; Merbach AE; Tóth E Dalton Trans; 2008 Mar; (9):1195-202. PubMed ID: 18283380 [TBL] [Abstract][Full Text] [Related]
7. Gadolinium(III) complexes of mono- and diethyl esters of monophosphonic acid analogue of DOTA as potential MRI contrast agents: solution structures and relaxometric studies. Lebdusková P; Hermann P; Helm L; Tóth E; Kotek J; Binnemans K; Rudovský J; Lukes I; Merbach AE Dalton Trans; 2007 Jan; (4):493-501. PubMed ID: 17213936 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of High Relaxivity Gadolinium AAZTA Tetramers as Building Blocks for Bioconjugation. Tripepi M; Capuana F; Gianolio E; Kock FVC; Pagoto A; Stefania R; Digilio G; Aime S Bioconjug Chem; 2018 Apr; 29(4):1428-1437. PubMed ID: 29470084 [TBL] [Abstract][Full Text] [Related]
9. Gd(DOTAla): a single amino acid Gd-complex as a modular tool for high relaxivity MR contrast agent development. Boros E; Polasek M; Zhang Z; Caravan P J Am Chem Soc; 2012 Dec; 134(48):19858-68. PubMed ID: 23157602 [TBL] [Abstract][Full Text] [Related]
10. Gadolinium(III) 1,2-hydroxypyridonate-based complexes: toward MRI contrast agents of high relaxivity. Xu J; Churchill DG; Botta M; Raymond KN Inorg Chem; 2004 Sep; 43(18):5492-4. PubMed ID: 15332797 [TBL] [Abstract][Full Text] [Related]
11. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action. Caravan P Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207 [TBL] [Abstract][Full Text] [Related]
12. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents. Laus S; Ruloff R; Tóth E; Merbach AE Chemistry; 2003 Aug; 9(15):3555-66. PubMed ID: 12898682 [TBL] [Abstract][Full Text] [Related]
14. Gadolinium(III) di- and tetrachelates designed for in vivo noncovalent complexation with plasma proteins: a novel molecular design for blood pool MRI contrast enhancing agents. Martin VV; Ralston WH; Hynes MR; Keana JF Bioconjug Chem; 1995; 6(5):616-23. PubMed ID: 8974462 [TBL] [Abstract][Full Text] [Related]
17. A novel cholic acid-based contrast enhancement agent for targeted MRI. Chong HS; Song HA; Lim S; Macrenaris K; Ma X; Lee H; Bui P; Meade T Bioorg Med Chem Lett; 2008 Apr; 18(7):2505-8. PubMed ID: 18337094 [TBL] [Abstract][Full Text] [Related]
18. Cyclen-based Gd Rashid HU; Martines MAU; Jorge J; de Moraes PM; Umar MN; Khan K; Rehman HU Bioorg Med Chem; 2016 Nov; 24(22):5663-5684. PubMed ID: 27729196 [TBL] [Abstract][Full Text] [Related]
19. Tris(pyrone) chelates of Gd(III) as high solubility MRI-CA. Puerta DT; Botta M; Jocher CJ; Werner EJ; Avedano S; Raymond KN; Cohen SM J Am Chem Soc; 2006 Feb; 128(7):2222-3. PubMed ID: 16478170 [TBL] [Abstract][Full Text] [Related]
20. Aggregation in amphiphilic macrocycle-substituted Gd(3+) DOTA-type chelates is affected by the regiochemistry of substitution. Webber BC; Cassino C; Botta M; Woods M Inorg Chem; 2015 Mar; 54(5):2085-7. PubMed ID: 25692481 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]